W. Marieke Schoonen

EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

Kausik K. Ray, Bart Molemans, W. Marieke Schoonen et al. · European Journal of Preventive Cardiology · 2020 · 767 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

W. Marieke Schoonen, Gena Kucera, Jenna E. Coalson et al. · British Journal of Haematology · 2009 · 300 citations · Full text

Public Health, Hematology, Clinical Epidemiology +6

Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

Mikkael A. Sekeres, W. Marieke Schoonen, Hagop M. Kantarjian et al. · JNCI Journal of the National Cancer Institute · 2008 · 245 citations · Full text

Medicine, Hematology, Internal Medicine +14

An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab)

Gregor Verhoef, Hans Erik Johnsen, Francesca Gaia Rossi et al. · Blood · 2008 · 233 citations

Medicine, Hematology, Internal Medicine +8

Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry

Judith Neukirchen, W. Marieke Schoonen, Corinna Strupp et al. · Leukemia Research · 2011 · 205 citations

Medicine, Hematology, Internal Medicine +11